The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.
Lewy Bodies Contain Altered α-Synuclein in Brains of Many Familial Alzheimer's Disease Patients with Mutations in Presenilin and Amyloid Precursor Protein Genes
Open accessAbstract
Missense mutations in the alpha-synuclein gene cause familial Parkinson's disease (PD), and alpha-synuclein is a major component of Lewy bodies (LBs) in sporadic PD, dementia with LBs (DLB), and the LB variant of Alzheimer's disease (AD). To determine whether alpha-synuclein is a component of LBs in familial AD (FAD) patients with known mutations in presenilin (n = 65) or amyloid precursor protein (n = 9) genes, studies were conducted with antibodies to alpha-, beta-, and gamma-synuclein. LBs were detected with alpha- but not beta- or gamma-synuclein antibodies in 22% of FAD brains, and alpha-synuclein-positive LBs were most numerous in amygdala where some LBs co-localized with tau-positive neurofibrillary tangles. As 12 (63%) of 19 FAD amygdala samples contained alpha-synuclein-positive LBs, these inclusions may be more common in FAD brains than previously reported. Furthermore, alpha-synuclein antibodies decorated LB filaments by immunoelectron microscopy, and Western blots revealed that the solubility of alpha-synuclein was reduced compared with control brains. The presence of alpha-synuclein-positive LBs was not associated with any specific FAD mutation. These studies suggest that insoluble alpha-synuclein aggregates into filaments that form LBs in many FAD patients, and we speculate that these inclusions may compromise the function and/or viability of affected neurons in the FAD brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“two studies have shown that individuals with PSEN1 mutations have increased, yet heterogeneous limbic LRP [22, 25].”
From α-synuclein in the pathophysiology of Alzheimer’s disease (2019) · cites this paper as [22]
In the citing paper
“co-morbid αSyn pathology has been reported in more than half of all autopsy-confirmed AD cases [22–24]”
From α-synuclein in the pathophysiology of Alzheimer’s disease (2019) · cites this paper as [22]
In the citing paper
“co-morbid αSyn pathology has been reported in more than half of all autopsy-confirmed AD cases [22–24]”
From α-synuclein in the pathophysiology of Alzheimer’s disease (2019) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Self-citationMutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Shi, S., Key, M. E., & Kalra, K. L. (1991) · Journal of Histochemistry & Cytochemistry · doi:10.1177/39.6.1709656 · Cited by 2,543
Staging of alzheimer's disease-related neurofibrillary changes
Braak, H., & Braak, E. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00021-6 · Cited by 2,357
Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., & Van Leuven, F. (1998) · Nature · doi:10.1038/34910 · Cited by 1,818
(1998) · Europe PMC (PubMed Central) · Cited by 1,594
Self-citationHYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542
Self-citation
Research works printed but not linked: 1
- Foncin, 1985, Demence presenile d'Alzheimer transmise'dans une famille etendue, Rev Neurol (Paris), 141, 194
Cited by
Sorted by citations
Items 201–300 of 532
Pathophysiology of synuclein aggregation in Lewy body disease
Mukaetova‐Ladinska, E. B., & McKeith, I. G. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.09.014 · Cited by 74
Pathology and Neurotransmitter Abnormalities of Dementia with Lewy Bodies
Duda, J. E. (2003) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000074677 · Cited by 73
Overk, C., Cartier, A. E., Shaked, G. M., Rockenstein, E. M., Ubhi, K. K., Spencer, B. J., Price, D. L., Patrick, C., Desplats, P., & Masliah, E. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-18 · Cited by 73
Retractedα-Synuclein amino terminus regulates mitochondrial membrane permeability
Shen, J., Du, T., Wang, X., Duan, C., Gao, G., Zhang, J., Lu, L., & Yang, H. (2014) · Brain Research · doi:10.1016/j.brainres.2014.09.046 · Cited by 72
Endogenous Aβ causes cell death via early tau hyperphosphorylation
Amadoro, G., Corsetti, V., Ciotti, M. T., Florenzano, F., Capsoni, S., Amato, G., & Calissano, P. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.06.005 · Cited by 74
Arima, K., Mizutani, T., Alim, A., Tonozuka-Uehara, H., Izumiyama, Y., Hirai, S., & Uéda, K. (2000) · Acta Neuropathologica · doi:10.1007/s004010050002 · Cited by 71
Williams, S. M., Schulz, P., & Sierks, M. R. (2015) · European Journal of Neuroscience · doi:10.1111/ejn.13056 · Cited by 71
The interrelationship of proteasome impairment and oligomeric intermediates in neurodegeneration
Deger, J. M., Gerson, J. E., & Kayed, R. (2015) · Aging Cell · doi:10.1111/acel.12359 · Cited by 69
Ravanidis, S., Bougea, A., Karampatsi, D., Papagiannakis, N., Maniati, M., Stefanis, L., & Doxakis, E. (2021) · Movement Disorders · doi:10.1002/mds.28467 · Cited by 63
The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer’s disease
for the Dominantly Inherited Alzheimer Network (DIAN), Twohig, D., Rodriguez-Vieitez, E., Sando, S. B., Berge, G., Lauridsen, C., Møller, I., Grøntvedt, G. R., Bråthen, G., Patra, K., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0624-z · Cited by 68
Familial Dementia With Lewy Bodies
Tsuang, D. W., Dalan, A. M., Eugenio, C. J., Poorkaj, P., Limprasert, P., Spada, A. R. L., Steinbart, E. J., Bird, T. D., & Leverenz, J. B. (2002) · Archives of Neurology · doi:10.1001/archneur.59.10.1622 · Cited by 67
Self-citationRey, N. L., George, S., & Brundin, P. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12299 · Cited by 67
Lewy bodies in progressive supranuclear palsy
Mori, H., Oda, M., Komori, T., Arai, N., Takanashi, M., Mizutani, T., Hirai, S., & Mizuno, Y. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0555-3 · Cited by 66
Alzheimer's and Parkinson's disease – overlapping or synergistic pathologies?
Kurosinski, P., Guggisberg, M., & Götz, J. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02246-8 · Cited by 66
Brain high-throughput multi-omics data reveal molecular heterogeneity in Alzheimer’s disease
Eteleeb, A. M., Novotny, B. C., Tarraga, C. S., Sohn, C., Dhungel, E., Brase, L., Nallapu, A., Buss, J., Farias, F., Bergmann, K., et al. (2024) · PLOS Biology · doi:10.1371/journal.pbio.3002607 · Cited by 64
Wakabayashi, K., Fukushima, T., Koide, R., Horikawa, Y., Hasegawa, M., Watanabe, Y., Noda, T., Eguchi, I., Morita, T., Yoshimoto, M., et al. (2000) · Acta Neuropathologica · doi:10.1007/s004010050049 · Cited by 64
Self-citationWei, J., Fujita, M., Nakai, M., Waragai, M., Sekigawa, A., Sugama, S., Takenouchi, T., Masliah, E., & Hashimoto, M. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080680 · Cited by 62
Giacomelli, C., Daniele, S., & Martini, C. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.01.017 · Cited by 71
Alzheimer’s disease and the autophagic-lysosomal system
Chung, K. M., Hernández, N., Sproul, A. A., & Yu, W. H. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2018.05.017 · Cited by 63
Papapetropoulos, S. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2006.12.011 · Cited by 65
A novel PSEN2 mutation associated with a peculiar phenotype
Piscopo, P., Marcon, G., Piras, M. R., Crestini, A., Campeggi, L. M., Deiana, E., Cherchi, R., Tanda, F., Deplano, A., Vanacore, N., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000310643.53587.87 · Cited by 64
Ferman, T. J., & Boeve, B. F. (2007) · Neurologic Clinics · doi:10.1016/j.ncl.2007.03.001 · Cited by 68
Late‐onset neurodegenerative diseases—the role of protein insolubility
Johnson, W. G. (2000) · Journal of Anatomy · doi:10.1046/j.1469-7580.2000.19640609.x · Cited by 61
Kayed, R., Dettmer, U., & Lesné, S. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-201965 · Cited by 63
da Silva, F. L., Cerqueira, E. C., de Freitas, M. S., Gonçalves, D. L., Costa, L. T., & Follmer, C. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.10.001 · Cited by 61
The interaction of α-synuclein and Tau: A molecular conspiracy in neurodegeneration?
Xu, Y., Uronen, R., & Huttunen, H. J. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2018.05.005 · Cited by 64
Compta, Y., & Révész, T. (2020) · Journal of Parkinson s Disease · doi:10.3233/jpd-202323 · Cited by 61
Rutherford, N. J., Brooks, M., & Giasson, B. I. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0357-9 · Cited by 55
Self-citationAlpha-Synuclein and Chaperones in Dementia With Lewy Bodies
Cantuti‐Castelvetri, I., Klucken, J., Ingelsson, M., Ramasamy, K., McLean, P. J., Frosch, M. P., Hyman, B. T., & Standaert, D. G. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000190063.90440.69 · Cited by 58
α-synuclein induced synapse damage is enhanced by amyloid-β1-42
Bate, C., Gentleman, S., & Williams, A. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-55 · Cited by 55
Beach, T., Malek-Ahmadi, M., ZAMRINI, E. Y., Adler, C. H., Sabbagh, M. N., Shill, H. A., Jacobson, S. A., Belden, C. M., Caselli, R. J., Woodruff, B. K., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217566 · Cited by 56
Tau Reduction Does Not Prevent Motor Deficits in Two Mouse Models of Parkinson's Disease
Morris, M., Koyama, A., Masliah, E., & Mucke, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029257 · Cited by 56
Yang, F., Uéda, K., Chen, P.-P., Ashe, K. H., & Cole, G. M. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02207-6 · Cited by 54
The Parkinson's disease-related genes act in mitochondrial homeostasis
Sai, Y., Zou, Z., Peng, K., & Dong, Z. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.06.007 · Cited by 55
From genetics to pathology: tau and a–synuclein assemblies in neurodegenerative diseases
Goedert, M., Spillantini, M. G., Serpell, L. C., Berriman, J. A., Smith, M. J., Jakes, R., & Crowther, R. A. (2001) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2000.0767 · Cited by 57
Zhu, X., Bøgh, H. O., & Gasser, R. B. (1999) · Electrophoresis · doi:10.1002/(sici)1522-2683(19991001)20:14 · Cited by 10
A novel presenilin mutation (M233V) causing very early onset Alzheimer's disease with Lewy bodies
Houlden, H., Crook, R., Dolan, R. J., McLaughlin, J., Révész, T., & Hardy, J. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02254-6 · Cited by 54
Iseki, E. (2004) · Neuropathology · doi:10.1111/j.1440-1789.2003.00530.x · Cited by 54
α‐Synuclein modifies huntingtin aggregation in living cells
Herrera, F., & Outeiro, T. F. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.11.019 · Cited by 53
Characteristics of alpha-synucleinopathy in centenarians
Ding, Z., Wang, Y., Jiang, Y., Hashizume, Y., Yoshida, M., Mimuro, M., Inagaki, T., & Iwase, T. (2006) · Acta Neuropathologica · doi:10.1007/s00401-005-0015-y · Cited by 53
Atsmon‐Raz, Y., & Miller, Y. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00204 · Cited by 56
Brain Aβ amyloidosis in APPsw mice induces accumulation of presenilin-1 and tau
Tomidokoro, Y., Harigaya, Y., Matsubara, E., Ikeda, M., Kawarabayashi, T., Shirao, T., Ishiguro, K., Okamoto, K., Younkin, S. G., & Shoji, M. (2001) · The Journal of Pathology · doi:10.1002/path.897 · Cited by 54
Giasson, B. I., Duda, J. E., Forman, M. S., Lee, V. M. ‐., & Trojanowski, J. Q. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7805 · Cited by 52
Self-citationIncreased unsaturated lipids underlie lipid peroxidation in synucleinopathy brain
Fu, Y., He, Y. Z., Phan, K., Bhatia, S., Pickford, R., Wu, P., Dzamko, N. L., Halliday, G. M., & Kim, W. S. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01469-7 · Cited by 53
Moda, F., Ciullini, A., Dellarole, I. L., Lombardo, A., Campanella, N., Bufano, G., Cazzaniga, F. A., & Giaccone, G. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2810255 · Cited by 49
Genetic association between the APOE * 4 allele and Lewy bodies in Alzheimer disease
Tsuang, D. W., Wilson, R. K., López, O. L., Luedecking‐Zimmer, E., Leverenz, J. B., DeKosky, S. T., Kamboh, M. I., & Hamilton, R. L. (2005) · Neurology · doi:10.1212/01.wnl.0000150892.81839.d1 · Cited by 50
Duka, T., & Sidhu, A. (2006) · Neurotoxicity Research · doi:10.1007/bf03033329 · Cited by 51
Glycosaminoglycans, Protein Aggregation and Neurodegeneration
Papy-García, D., Christophe, M., Huynh, M. B., Siñeriz, F., Sissoëff, L., Sepulveda-Diaz, J. E., & Raisman‐Vozari, R. (2011) · Current Protein and Peptide Science · doi:10.2174/138920311795860188 · Cited by 53
Lewy bodies are not increased in progressive supranuclear palsy compared with normal controls
Tsuboi, Y., Ahlskog, J. E., Apaydın, H., Parisi, J. E., & Dickson, D. W. (2001) · Neurology · doi:10.1212/wnl.57.9.1675 · Cited by 48
Current Concepts of Neurodegenerative Diseases
Kovács, G. G. (2014) · EMJ Neurology · doi:10.33590/emjneurol/10314777 · Cited by 47
Lim, K. H. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00158 · Cited by 46
Lewy body pathology exacerbates brain hypometabolism and cognitive decline in Alzheimer’s disease
Collij, L. E., Mastenbroek, S. E., Mattsson, N., Strandberg, O. T., Smith, R. A., Janelidze, S., Palmqvist, S., Ossenkoppele, R., & Hansson, O. (2024) · Nature Communications · doi:10.1038/s41467-024-52299-1 · Cited by 46
Vöglein, J., Paumier, K. L., Jucker, M., Preische, O., McDade, E., Hassenstab, J. J., Benzinger, T. L. S., Noble, J. M., Berman, S., Graff‐Radford, N. R., et al. (2019) · Brain · doi:10.1093/brain/awz050 · Cited by 46
Self-citationDNA induced folding/fibrillation of alpha-synuclein: new insights in Parkinson's disease
Hegde, M. L. (2009) · Frontiers in bioscience · doi:10.2741/3628 · Cited by 46
Bi, C., Bi, S., & Li, B. (2018) · Aging and Disease · doi:10.14336/ad.2018.0425 · Cited by 46
Kaneko, H., Kakita, A., Kasuga, K., Nozaki, H., Ishikawa, A., Miyashita, A., Kuwano, R., Ito, G., Iwatsubo, T., Takahashi, H., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4244-07.2007 · Cited by 44
Self-citationFunctional Genomics meets neurodegenerative disorders
Hoerndli, F. J., David, D. C., & Götz, J. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.07.002 · Cited by 44
α-Synuclein: A potent inducer of tau pathology
Geddes, J. W. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.12.002 · Cited by 45
NACP/α-synuclein immunoreactivity in diffuse neurofibrillary tangles with calcification (DNTC)
Yokota, O., Terada, S., Ishizu, H., Tsuchiya, K., Kitamura, Y., Ikeda, K., Uéda, K., & Kuroda, S. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0545-5 · Cited by 41
The genetics of disorders withsynuclein pathology and parkinsonism
Farrer, M. J. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.10.1901 · Cited by 43
Cerebrospinal fluid α‐synuclein contributes to the differential diagnosis of Alzheimer's disease
Shi, M., Tang, L., Toledo, J. B., Ginghina, C., Wang, H., Aro, P., Jensen, P. H., Weintraub, D., Chen‐Plotkin, A. S., Irwin, D. J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.015 · Cited by 42
Self-citationTosun, D., Hausle, Z., Thropp, P., Concha‐Marambio, L., Lamoureux, J., Lebovitz, R. M., Shaw, L. M. J., Singleton, A., Weiner, M. W., Initiative, T. A. D. N., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14276 · Cited by 42
Alzheimer's disease neuropathology and its estimation with fluid and imaging biomarkers
Thal, D. R., Poesen, K., Vandenberghe, R. R., & Meyer, S. D. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00819-y · Cited by 55
Yokota, O., Terada, S., Ishizu, H., Ujike, H., Ishihara, T., Nakashima, H., Yasuda, M., Kitamura, Y., Uéda, K., Checler, F., et al. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0596-7 · Cited by 42
Lewy body pathology is a frequent co-pathology in familial Alzheimer's disease
Trembath, Y., Rosenberg, C., Ervin, J. F., Schmechel, D. E., Gaskell, P. C., Pericak‐Vance, M. A., Vance, J. M., & Hulette, C. M. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0670-9 · Cited by 42
Hanson, J. C., & Lippa, C. F. (2009) · International review of neurobiology · doi:10.1016/s0074-7742(09)00411-5 · Cited by 41
Self-citationTau and α-Synuclein Inclusions in a Case of Familial Frontotemporal Dementia and Progressive Aphasia
Yancopoulou, D., Xuereb, J. H., Crowther, R. A., Hodges, J. R., & Spillantini, M. G. (2005) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/64.3.245 · Cited by 40
Tau-positive glial cytoplasmic granules in multiple system atrophy
Nagaishi, M., Yokoo, H., & Nakazato, Y. (2010) · Neuropathology · doi:10.1111/j.1440-1789.2010.01159.x · Cited by 39
On the ‘classification’ of neurodegenerative disorders: discrete entities, overlap or continuum?
Armstrong, R. A. (2012) · Folia Neuropathologica · doi:10.5114/fn.2012.30521 · Cited by 41
Functional Genomics meets neurodegenerative disorders
David, D. C., Hoerndli, F. J., & Götz, J. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.07.001 · Cited by 39
Lack of Familial Aggregation of Parkinson Disease and Alzheimer Disease
Levy, G., Louis, E. D., Mejia‐Santana, H., COTE, L. J., Andrews, H., Harris, J. M., Waters, C., Ford, B., Frucht, S. J., Fahn, S., et al. (2004) · Archives of Neurology · doi:10.1001/archneur.61.7.1033 · Cited by 40
Levin, J., Baiardi, S., Quadalti, C., Rossi, M., Mammana, A., Vöglein, J., Bernhardt, A. M., Perrin, R. J., Jucker, M., Preische, O., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13818 · Cited by 39
Self-citationGauthier, S. G., Zhang, H., Ng, K. P., Pascoal, T. A., & Rosa‐Neto, P. (2018) · Translational Neurodegeneration · doi:10.1186/s40035-018-0117-9 · Cited by 42
Ichibangase, T., Saimaru, H., Takamura, N., Kuwahara, T., Koyama, A., Iwatsubo, T., & Imai, K. (2007) · Biomedical Chromatography · doi:10.1002/bmc.931 · Cited by 40
Self-citationSebeo, J., Hof, P. R., & Perl, D. P. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0840-4 · Cited by 39
In vitro models of synucleinopathies: informing on molecular mechanisms and protective strategies
Marvian, A. T., Koss, D. J., Aliakbari, F., Morshedi, D., & Outeiro, T. F. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14707 · Cited by 38
α-Synuclein, Aβ and Alzheimer's disease
Wirths, O. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00339-1 · Cited by 37
Molecular Pathology of Alzheimer’s Disease and Related Disorders
Ginsberg, S. D., Schmidt, M. L., Crino, P. B., Eberwine, J. H., Lee, V. M. ‐., & Trojanowski, J. Q. (1999) · Cerebral cortex · doi:10.1007/978-1-4615-4885-0_17 · Cited by 38
Self-citationHippocampal Sclerosis of Aging Can Be Segmental
Ighodaro, E. T., Jicha, G. A., Schmitt, F. A., Neltner, J. H., Abner, E. L., Kryscio, R. J., Smith, C. D., Duplessis, T., Anderson, S., Patel, E., et al. (2015) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000204 · Cited by 37
Kaul, T. K., Credle, J. J., Haggerty, T., Oaks, A. W., Masliah, E., & Sidhu, A. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-79 · Cited by 37
Limited proteolysis of NACP/α-synuclein
Hossain, S., Alim, A., Takeda, K., Kaji, H., Shinoda, T., & Uéda, K. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3608 · Cited by 37
Caligiore, D., Giocondo, F., & Silvetti, M. (2022) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2022.09.007 · Cited by 40
Pan, C., Korff, A., Galasko, D. R., Ginghină, C., Peskind, E. R., Li, G., Quinn, J. F., Montine, T. J., Cain, K. C., Shi, M. Y., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-143099 · Cited by 36
Synthesis and characterization of high affinity fluorogenic α-synuclein probes
Lengyel‐Zhand, Z., Ferrie, J. J., Janssen, B., Hsieh, C., Graham, T. J. A., Xu, K.-Y., Haney, C. M., Lee, V. M. ‐., Trojanowski, J. Q., Petersson, E. J., et al. (2020) · Chemical Communications · doi:10.1039/c9cc09849f · Cited by 37
Self-citationPiras, I. S., Bleul, C., Schrauwen, I., Talboom, J. S., Llaci, L., Both, M. D. D., Naymik, M., Halliday, G. M., Bettencourt, C., Holton, J. L., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00950-5 · Cited by 37
Clarimón, J., Molina‐Porcel, L., Gómez‐Isla, T., Blesa, R., Guardia‐Laguarta, C., González‐Neira, A., Estorch, M., Grau, J. M., Barraquer, L., Roig, C., et al. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181927577 · Cited by 36
Węgiel, J., Flory, M. J., Kuchna, I., Nowicki, K., Wegiel, J., Ma, S. Y., Zhong, N., Wierzba‐Bobrowicz, T., de Leon, M., Lai, F., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01300-9 · Cited by 35
Luteinizing hormone as a key player in the cognitive decline of Alzheimer's disease
Burnham, V. L., & Thornton, J. E. (2015) · Hormones and Behavior · doi:10.1016/j.yhbeh.2015.05.010 · Cited by 34
α-Synuclein oligomers and fibrils: partners in crime in synucleinopathies
Bigi, A., Cascella, R., & Cecchi, C. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.371345 · Cited by 38
Overlaps and divergences between tauopathies and synucleinopathies: a duet of neurodegeneration
Li, W., & Li, J. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00407-y · Cited by 37
Co-occurrence of Parkinson's disease with progressive supranuclear palsy
Judkins, A. R., Forman, M. S., Uryu, K., Hinkle, D., Asbury, A. K., Lee, V. M. ‐., & Trojanowski, J. Q. (2002) · Acta Neuropathologica · doi:10.1007/s00401-001-0483-7 · Cited by 34
Self-citationα-Synuclein oligomerization: a role for lipids?
Welch, K., & Yuan, J. (2003) · Trends in Neurosciences · doi:10.1016/j.tins.2003.08.001 · Cited by 34
Rutherford, N. J., Dhillon, J.-K. S., Riffe, C. J., Howard, J. K., Brooks, M., & Giasson, B. I. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx371 · Cited by 33
Self-citationYahi, N., Scala, C. D., Chahinian, H., & Fantini, J. (2021) · Glycoconjugate Journal · doi:10.1007/s10719-021-10012-0 · Cited by 33
Alzheimer's disease due to an intronic presenilin-1 (PSEN1 intron 4) mutation
Janssen, J. C., Hall, M., Fox, N. C., Harvey, R. J., Beck, J. A., Dickinson, A., Campbell, T., Collinge, J., Lantos, P. L., Cipolotti, L., et al. (2000) · Brain · doi:10.1093/brain/123.5.894 · Cited by 36
Ubiquitinated inclusions and neuronal cell death.
Lang‐Rollin, I., Rideout, H. J., & Stefanis, L. (2003) · PubMed · doi:10.14670/hh-18.509 · Cited by 33
Heterotypic interactions in amyloid function and disease
Konstantoulea, K., Louros, N. N., Rousseau, F., & Schymkowitz, J. W. H. (2021) · FEBS Journal · doi:10.1111/febs.15719 · Cited by 34
Amyloid-β oligomer synaptotoxicity is mimicked by oligomers of the model protein HypF-N
Tatini, F., Pugliese, A. M., Traini, C., Niccoli, S., Maraula, G., Dami, T. E., Mannini, B., Scartabelli, T., Pedata, F., Casamenti, F., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.03.020 · Cited by 33
Trojanowski, J. Q., & Lee, V. M.-Y. (2001) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(00)00065-1 · Cited by 32
Self-citationα-Synuclein in Familial Alzheimer Disease
Lippa, C. F. (2001) · Archives of Neurology · doi:10.1001/archneur.58.11.1817 · Cited by 32
Self-citation
Metadata
- Authors
- Lippa, C. F., Fujiwara, H., Mann, D. M. A., Giasson, B., Baba, M., Schmidt, M. L., Nee, L. E., O'Connell, B., Pollen, D. A., St. George-Hyslop, P., Ghetti, B., Nochlin, D., Bird, T. D., Cairns, N. J., Lee, V. M.-Y., Iwatsubo, T., & Trojanowski, J. Q.
- Affiliations
- The University of Tokyo (JP)
- University of Manchester (GB)
- University of Pennsylvania (US)
- National Institute of Neurological Disorders and Stroke (US)
- University of Massachusetts Chan Medical School (US)
- Indiana University Hospital (US)
- University of Washington (US)
- Corresponding author
- Lippa, Carol F.
- ORCID
- Venue
- The American Journal of Pathology
- Publisher
- Elsevier BV
- Published
- 1998-11
- Volume
- 153
- Issue
- 5
- Pages
- 1365-1370
- ISSN
- 0002-9440 (ISSN-L)
- PMC
- PMC1853391
- OpenAlex
- W2066155243
- Cited by
- 533
- References
- 35
- Citations by year
- 2026: 10 · 2025: 17 · 2024: 23 · 2023: 16 · 2022: 19 · 2021: 21 · 2020: 19 · 2019: 17 · 2018: 16 · 2017: 9 · 2016: 11 · 2015: 13 · 2014: 25 · 2013: 13 · 2012: 11
- FWCI
- 17.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- American Journal Of Pathology (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (7r29ag013623-06)
- National Institute on Aging (P30AG010133, AG09215, U01AG006781, AG13623, P30AG010124, P01AG009215, AG-10124, P50AG005136)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Lewy bodies, alpha-synuclein, familial Alzheimer's disease, presenilin mutations, amyloid precursor protein mutations, amygdala, alpha-synuclein aggregation, protein insolubility, immunoelectron microscopy
- MeSH terms
- Adult, Aged, Alzheimer Disease, Brain, Female, Humans, Immunohistochemistry, Male, Membrane Proteins, Middle Aged, Mutation, Nerve Tissue Proteins, Blotting, Western, Microscopy, Immunoelectron, Amyloid beta-Protein Precursor, Lewy Bodies, Synucleins, alpha-Synuclein, gamma-Synuclein, Presenilin-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
